EMG
CRSP icon

Ellington Management Group’s CRISPR Therapeutics CRSP Stock Holding History

Ellington Management Group’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-28,100
Closed -$1M – 594
2019
Q1 		$1M Buy
+28,100
New +$1M 0.18% 120